What's Happening?
Lifecore Biomedical, Inc., a fully integrated injectables contract development and manufacturing organization, announced its participation in the CDMO Live Europe conference. The event is scheduled to
take place from May 19-21, 2026, in Rotterdam, Netherlands. Lifecore's Director of Manufacturing Science and Technology, Ryan Swanson, Ph.D., will be involved in a panel discussion titled 'The Tech Transfer Playbook: Right First Time Strategies.' The company will also host meetings with prospective customers to discuss process development and manufacturing services for injectables programs. Lifecore is known for its expertise in the development, fill, and finish of sterile injectable pharmaceutical products, including complex formulations.
Why It's Important?
Lifecore Biomedical's participation in the CDMO Live Europe conference underscores its role as a significant player in the pharmaceutical manufacturing sector. By engaging with global and emerging biopharmaceutical and biotechnology companies, Lifecore aims to expand its market presence and foster partnerships that could lead to advancements in injectable pharmaceutical products. This participation highlights the company's commitment to innovation and excellence in manufacturing, which is crucial for maintaining competitive advantage in the healthcare industry. The conference provides a platform for Lifecore to showcase its capabilities and potentially secure new business opportunities, thereby contributing to its growth and the broader pharmaceutical sector.
What's Next?
During the conference, Lifecore will engage with potential clients and industry peers, which could lead to new collaborations and business deals. The outcomes of these interactions may influence Lifecore's strategic direction and operational focus in the coming months. The company's participation in the panel discussion may also provide insights into industry trends and best practices, which could inform Lifecore's future initiatives and product development strategies.
